Venture
Avenzo Therapeutics, Inc.
Latest Form D 2025-09-05- CIK 1947742
- State CA
- Biotechnology
- 2 Form D offerings since 2022-09-29
- Total sold
- $433M
- across 2 offerings
- Rounds
- 2
- Form D offerings since 2022-09-29
- Latest round
- $47.2M
- 2025-09-05 · 021-556725
- Investors
- 20
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2025-09-05 · $47.2M
- 2022-09-29$386M021-460216
- 2025-09-05$47.2M021-556725
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($386M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-556725 | First filed2025-09-05 | Latest2025-09-05 | Sought$75M | Sold$47.2M | Investors20 | Exemptions506(b) |
| 021-460216 | First filed2022-09-29 | Latest2024-11-20 | Sought$386M | Sold$386M | Investors22 | Exemptions506(b) |
Who backs Avenzo Therapeutics, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2025-09-05
| Name | Relationship |
|---|---|
| Athena Countouriotis | RelationshipExecutive Officer, Director |
| Brian Sun | RelationshipExecutive Officer |
| Mohammad Hirmand | RelationshipExecutive Officer |
| Simeon George | RelationshipDirector |
| Carl Gordon | RelationshipDirector |
| Jakob Dupont, M.D., M.A. | RelationshipDirector |
| Paolo Tombesi | RelationshipExecutive Officer |
| Scott Lipman | RelationshipExecutive Officer |
| Judith Li | RelationshipDirector |
| Garry Nicholson | RelationshipDirector |
| Patrick Machado | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2022-09-29
- Latest filing
- 2025-09-05
Who backs Avenzo Therapeutics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗